Lv6
2908 积分 2022-07-12 加入
Lessons learned from QT prolongation risk assessment for antibody-drug conjugates in oncology
14天前
已完结
QT Prolongation Risk of Antibody–Drug Conjugates
14天前
已完结
Clinical Pharmacology Considerations in Antibody-Drug Conjugates Development
1个月前
已关闭
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
2个月前
已完结
Aggregate data modelling: A fast implementation for fitting pharmacometrics models to summary-level data in R
2个月前
已完结
Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision Dosing
3个月前
已完结
Review of tools to support Target Trial Emulation
3个月前
已完结
Endpoint Exposure‐Response Analyses in the Presence of Concurrent Dose Modification During Clinical Trials
3个月前
已完结
Clinical Pharmacology Insights for Small Molecule and Antibody‐Based Drug Products Approved for Multiple Immune‐Mediated Indications
3个月前
已完结
Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy
4个月前
已完结
皖公网安备34019202002308
